Imagion Biosystems has announced and amendment to the proposed timetable for the Pro-Rata Renounceable Rights Issue as announced on Monday, 28 October 2019.
Read the amended timetable.
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December
December 2, 2025
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2